Ozenoxacin, also known as GF-001001-00; M-5120; T-3912; GF-00100100, is an experimental quinolone antibiotic being developed for the treatment of impetigo and other dermatological bacterial infections. Ozenoxacin is active against some bacteria that have developed resistance to currently used quinolone and fluoroquinolone antibiotics.
Yu, Yang; Chen, Jingjin; Zhou, Huayin; Wang, Linyong; Zhang, Zhiqiang; Sun, Yuanjun; Qiu, Xin; Wang, Yuliang. Preparation method of intermediate of ozenoxacin antibacterial drug by Suzuki coupling reaction, and ozenoxacin from the intermediate. CN 108299480. (Assignee Shandong Bestcomm Pharmaceutical Co., Ltd., Peop. Rep. China)
Kuroda, Hiroshi; Hayashi, Kazuya; Tohdo, Keisuke; Yokotani, Junichi; Takamatsu, Tamotsu. 6-Substituted alkylamino-3-pyridylboric acid derivative or salt thereof and processes for producing them. WO 2002062805. (Assignee Toyama Chemical Co., Ltd., Japan)
